Cho Yoon Keun, Son Yeonho, Saha Abhirup, Kim Doeun, Choi Cheoljun, Kim Minsu, Park Ji-Hyun, Im Hyeonyeong, Han Juhyeong, Kim Kyungmin, Jung Young-Suk, Yun Jeanho, Bae Eun Ju, Seong Je Kyung, Lee Mi-Ock, Lee Sangkyu, Granneman James G, Lee Yun-Hee
College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea.
Nat Metab. 2021 Mar;3(3):428-441. doi: 10.1038/s42255-021-00362-2. Epub 2021 Mar 23.
Obesity reduces adipocyte mitochondrial function, and expanding adipocyte oxidative capacity is an emerging strategy to improve systemic metabolism. Here, we report that serine/threonine-protein kinase 3 (STK3) and STK4 are key physiological suppressors of mitochondrial capacity in brown, beige and white adipose tissues. Levels of STK3 and STK4, kinases in the Hippo signalling pathway, are greater in white than brown adipose tissues, and levels in brown adipose tissue are suppressed by cold exposure and greatly elevated by surgical denervation. Genetic inactivation of Stk3 and Stk4 increases mitochondrial mass and function, stabilizes uncoupling protein 1 in beige adipose tissue and confers resistance to metabolic dysfunction induced by high-fat diet feeding. Mechanistically, STK3 and STK4 increase adipocyte mitophagy in part by regulating the phosphorylation and dimerization status of the mitophagy receptor BNIP3. STK3 and STK4 expression levels are elevated in human obesity, and pharmacological inhibition improves metabolic profiles in a mouse model of obesity, suggesting STK3 and STK4 as potential targets for treating obesity-related diseases.
肥胖会降低脂肪细胞的线粒体功能,而增强脂肪细胞的氧化能力是改善全身代谢的一种新策略。在此,我们报告丝氨酸/苏氨酸蛋白激酶3(STK3)和STK4是棕色、米色和白色脂肪组织中线粒体能力的关键生理抑制因子。STK3和STK4是Hippo信号通路中的激酶,其在白色脂肪组织中的水平高于棕色脂肪组织,棕色脂肪组织中的水平在冷暴露时受到抑制,而在手术去神经支配后大幅升高。Stk3和Stk4的基因失活增加了线粒体质量和功能,稳定了米色脂肪组织中的解偶联蛋白1,并赋予对高脂饮食诱导的代谢功能障碍的抗性。从机制上讲,STK3和STK4部分通过调节线粒体自噬受体BNIP3的磷酸化和二聚化状态来增加脂肪细胞的线粒体自噬。在人类肥胖中,STK3和STK4的表达水平升高,药物抑制可改善肥胖小鼠模型的代谢状况,这表明STK3和STK4是治疗肥胖相关疾病的潜在靶点。